News

Hawk IR will continue to operate as Hawk IR International under the Fluke electronics industrial division and will continue to service its customers and partners globally. Fluke said

Under the research collaboration with professor Jack Schalken (laboratory of experimental urology), InteRNA’s lentiviral-based microRNA (miRNA) overexpression library will be applied in multi-parametric, high-throughput functional screening assays to

Currently Sherman is a senior vice president and general manager. He will report to John E. McGlade, chairman, president and chief executive officer. He will have responsibility for

The primary objective of this multicenter, randomized, placebo-controlled, crossover study is the assessment of safety, tolerability and efficacy of ARX-02 relative to placebo in cancer patients experiencing episodic

Omnitrope is reported to be the first version of a previously approved recombinant biotechnology drug to be approved by Health Canada under the regulatory term ‘subsequent entry biologic’.

The trial will enroll approximately 400 pediatric, geriatric and oncology patients at three sites who will be treated with either the novel guide wire-assisted peripheral IV catheter or

The results describe a new oral formulation of Irinotecan (IRN-SRN) encapsulated into nanoparticles allowing an oral release of the molecule. The company said that the aim of this

Under the agreement, Medicines for Malaria Venture (MMV) will have access to the Pfizer library of novel chemical entities, in order to screen it for compounds that have

With this acquisition, Schwabe will expand its presence in Austria and central & eastern Europe (CEE). Dirk Reischig, chairman and CEO of Dr Willmar Schwabe Pharmaceuticals, said: “We